Cholestyramine

Dosage for Cholestyramine must be individualized based on the patient's specific condition and response to therapy.

• For Hypercholesterolemia: The typical starting dose for adults is 4 grams (one scoop or packet) taken once or twice daily. Depending on the cholesterol response, your healthcare provider may gradually increase the dose. The standard maintenance range is 8 to 16 grams per day, divided into two doses. The maximum recommended daily dose is 24 grams (six doses).
• For Pruritus: The usual dose is 4 to 8 grams daily.
• For Bile Acid Diarrhea (Off-label): Dosing typically starts low at 4 grams daily and is titrated (adjusted) based on stool consistency.

Cholestyramine can be used in children, but it requires careful monitoring of growth and nutritional status, as it can interfere with the absorption of fat-soluble vitamins.

• Standard Pediatric Dose: The dosage is usually calculated based on body weight or body surface area. A common starting dose is 240 mg/kg/day of anhydrous cholestyramine resin, divided into two or three doses.
• Maximum Dose: Generally, the pediatric dose should not exceed 8 grams per day to minimize the risk of severe constipation and nutritional deficiencies.

Renal Impairment

Because Cholestyramine is not absorbed and is not excreted by the kidneys, no specific dose adjustments are required for patients with kidney disease. However, patients with renal impairment should be monitored for hyperchloremic acidosis (a type of electrolyte imbalance), as the resin exchanges chloride ions for bile acids.

Hepatic Impairment

No dosage adjustment is necessary for liver impairment. In fact, the drug is specifically used to treat symptoms of certain liver diseases. However, it should be avoided in patients with complete biliary obstruction, as the drug cannot work if bile cannot reach the intestine.

Elderly Patients

Older adults should start at the lower end of the dosing range. The primary concern in the elderly is the increased risk of severe constipation and fecal impaction. Healthcare providers often recommend increased fluid and fiber intake for these patients.

NEVER take Cholestyramine powder in its dry form. Doing so can lead to accidental inhalation or esophageal irritation/blockage.

1. 1Preparation: Mix one dose (4g) with at least 2 to 6 ounces (60-180 mL) of liquid. Water, non-carbonated fruit juices, or skim milk are preferred.
2. 2Mixing: Stir the mixture until it is as uniform as possible. The powder will not dissolve completely; it will remain as a suspension. You may also mix it into 'wet' foods like applesauce, crushed pineapple, or thin soups.
3. 3Timing: For maximum effectiveness in lowering cholesterol, Cholestyramine is usually taken at mealtime. If you take other medications, you must take them at least 1 hour before or 4 to 6 hours after taking Cholestyramine to prevent absorption issues.
4. 4Storage: Store the powder at room temperature (68°F to 77°F) away from moisture and heat.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to 'catch up.'

An overdose of Cholestyramine is not typically life-threatening because the drug is not absorbed. The primary risk is severe gastrointestinal obstruction.

• Symptoms: Severe abdominal pain, bloating, or the inability to have a bowel movement.
• Emergency Measures: Contact your local poison control center or seek emergency medical care. Treatment usually involves monitoring and managing the potential for intestinal blockage.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as your cholesterol levels may rise rapidly upon discontinuation.

The most frequent side effects associated with Cholestyramine are gastrointestinal in nature, as the drug remains localized in the digestive tract.

• Constipation: This is the most common complaint, occurring in up to 20% of patients. It can be severe, especially in older adults or those taking high doses. It may feel like infrequent bowel movements, straining, or hard stools.
• Abdominal Pain and Cramping: Patients often report a 'heavy' feeling in the stomach or general discomfort.
• Flatulence (Gas): Increased gas production is common as the body adjusts to the resin.
• Nausea: Some patients feel mildly nauseous shortly after consuming the suspension, often due to the texture and volume of the liquid.

• Bloating and Distention: A feeling of fullness or swelling in the abdominal area.
• Heartburn (Dyspepsia): Acid reflux or a burning sensation in the chest or throat.
• Vomiting: Less common than nausea but can occur if the suspension is consumed too quickly.
• Diarrhea: While often used to treat diarrhea, some patients may experience 'paradoxical' diarrhea or loose stools initially.
• Irritation of the Perianal Area: The presence of the resin in the stool can sometimes cause skin irritation during bowel movements.

• Fecal Impaction: A large, hard mass of stool that gets stuck in the colon or rectum.
• Intestinal Obstruction: A complete blockage of the bowel, which is a medical emergency.
• Pancreatitis: Inflammation of the pancreas, which may present as severe upper abdominal pain radiating to the back.
• Gallstones: Changes in bile acid composition may theoretically increase the risk of cholelithiasis (gallstones).
• Hyperchloremic Acidosis: A condition where there is too much chloride in the blood, leading to an acid-base imbalance.

> Warning: Stop taking Cholestyramine and call your doctor immediately if you experience any of these serious symptoms.

• Severe Constipation or Inability to Pass Gas: This may indicate a bowel obstruction.
• Unusual Bleeding or Bruising: Cholestyramine can interfere with Vitamin K absorption. Vitamin K is essential for blood clotting; a deficiency can lead to internal bleeding or easy bruising.
• Severe Abdominal Pain: Especially if accompanied by fever or vomiting.
• Black, Tarry Stools: This could indicate bleeding in the upper gastrointestinal tract.
• Difficulty Swallowing: If the powder was not mixed with enough liquid, it could cause esophageal irritation.

• Vitamin Deficiencies: Long-term use of Cholestyramine can lead to the malabsorption of fat-soluble vitamins (A, D, E, and K). Patients on chronic therapy may require supplementation. Symptoms of deficiency include night blindness (Vitamin A), bone thinning (Vitamin D), and bleeding issues (Vitamin K).
• Folic Acid Deficiency: Cholestyramine can also bind to folate in the gut, potentially leading to anemia.
• Tooth Decay and Enamel Erosion: If the suspension is held in the mouth for extended periods, the sugar content (in standard versions) and the acidic nature of the resin can damage teeth. It is recommended to rinse the mouth after each dose.
• Osteoporosis: Secondary to long-term Vitamin D and calcium malabsorption.

No FDA black box warnings for Cholestyramine. However, the FDA emphasizes the risk of drug interactions and the necessity of mixing the powder with fluids to prevent esophageal injury.

Report any unusual symptoms to your healthcare provider. Your doctor may monitor your blood levels of vitamins and minerals periodically during long-term treatment.

Cholestyramine is generally safe because it is not absorbed into the bloodstream; however, its physical presence in the gut and its binding properties create several safety considerations. Patients must be aware that this medication can interfere with the absorption of almost any other oral medication and many essential nutrients.

No FDA black box warnings for Cholestyramine. It has a long safety record when used according to professional guidelines.

• Gastrointestinal Disorders: Cholestyramine should be used with extreme caution in patients with a history of constipation, hemorrhoids, or bowel obstruction. The resin can exacerbate these conditions significantly.
• Phenylketonuria (PKU): Some 'light' or 'sugar-free' versions of Cholestyramine contain aspartame, which is a source of phenylalanine. Patients with PKU must check the label and consult their doctor before using these specific formulations.
• Bleeding Tendencies: Because the drug can cause Vitamin K deficiency, patients with existing bleeding disorders or those on anticoagulants (blood thinners) require very close monitoring.
• Electrolyte Imbalance: The resin releases chloride ions in exchange for bile acids. In some patients, particularly those with kidney disease or children, this can lead to hyperchloremic acidosis (excess acid in the blood).
• Hypersensitivity: While rare, allergic reactions to the resin or the flavoring/coloring agents can occur. Seek emergency care for hives, swelling of the face, or difficulty breathing.

To ensure the safety and efficacy of Cholestyramine, healthcare providers typically order the following tests:

• Lipid Panel: To monitor LDL, HDL, and total cholesterol levels. Interestingly, Cholestyramine can sometimes increase triglyceride levels; if triglycerides exceed 400 mg/dL, the drug may need to be discontinued.
• Prothrombin Time (PT/INR): If a patient is on long-term therapy or shows signs of bruising, this test checks how well the blood is clotting (monitoring Vitamin K status).
• Vitamin Levels: Periodic checks of Vitamin A, D, and E levels, especially in children or elderly patients.
• Serum Electrolytes: To check for signs of acidosis or chloride imbalance.

Cholestyramine does not cross the blood-brain barrier and does not cause drowsiness or cognitive impairment. It is generally considered safe to drive or operate machinery while taking this medication.

Alcohol does not directly interact with Cholestyramine in the gut. However, alcohol can significantly raise triglyceride levels. Since Cholestyramine can also increase triglycerides, combining the two may lead to very high levels of fat in the blood, increasing the risk of pancreatitis. It is best to limit alcohol consumption while on this medication.

Do not stop taking Cholestyramine abruptly without consulting your doctor. If you stop the medication, your cholesterol levels will likely return to their high baseline within a few weeks. If you are taking other medications (like Digoxin or Warfarin) that were being bound by Cholestyramine, stopping the resin could lead to a sudden, dangerous increase in the absorption of those other drugs.

> Important: Discuss all your medical conditions, especially any history of stomach or bowel problems, with your healthcare provider before starting Cholestyramine.

There are no drugs that are strictly 'contraindicated' in the sense that they can never be used by the same patient, but there are drugs that must not be taken at the same time as Cholestyramine. If taken together, Cholestyramine will bind the other drug, rendering it completely ineffective. This is particularly dangerous for life-sustaining medications.

• Warfarin (Coumadin): Cholestyramine can bind Warfarin, reducing its blood-thinning effect and increasing the risk of clots. Conversely, it can also cause Vitamin K deficiency, which increases the effect of Warfarin and the risk of bleeding. Patients on this combination need frequent INR monitoring.
• Thyroid Hormones (Levothyroxine): Cholestyramine significantly reduces the absorption of thyroid medication. This can lead to hypothyroidism (underactive thyroid). Levothyroxine must be taken at least 4 hours after Cholestyramine.
• Digoxin (Lanoxin): This heart medication is easily bound by the resin. Reduced absorption can lead to heart rhythm problems or heart failure exacerbation.
• Mycophenolate Mofetil: This immunosuppressant used after organ transplants can be bound by Cholestyramine, potentially leading to transplant rejection.

• Thiazide Diuretics (e.g., Hydrochlorothiazide): Reduced absorption can lead to poor blood pressure control.
• Beta-Blockers (e.g., Propranolol): The effectiveness of these heart and blood pressure medications may be diminished.
• Corticosteroids: Absorption may be delayed or reduced.
• Oral Contraceptives: There is a theoretical risk that Cholestyramine could reduce the effectiveness of birth control pills. Discuss backup contraception with your doctor.

• High-Fat Meals: While Cholestyramine is taken with meals, extremely high-fat meals may increase the risk of 'steatorrhea' (fatty, foul-smelling stools) because the resin interferes with fat digestion.
• Dairy: Some patients find that mixing the powder with milk increases bloating or gas.

• Fat-Soluble Vitamins (A, D, E, K): Cholestyramine will prevent the absorption of these supplements. They should be taken at the 'safe' interval (1 hour before or 4-6 hours after).
• Iron and Zinc: There is evidence that the resin may bind certain minerals, potentially leading to deficiencies over time.

Cholestyramine does not typically interfere with the chemical analysis of lab tests, but it drastically changes the physiological results of lipid panels and coagulation tests, as intended.

Management Strategy: The Timing Rule

To minimize interactions, follow the 1 and 4/6 Rule:

1. 1Take other medications at least 1 hour before taking Cholestyramine.
2. 2OR, take other medications at least 4 to 6 hours after taking Cholestyramine.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter pain relievers or vitamins can be affected by Cholestyramine.

• Complete Biliary Obstruction: Cholestyramine is absolutely contraindicated in patients where bile is not secreted into the intestine. Since the drug's mechanism depends on binding bile in the gut, it cannot work if bile cannot reach the lumen. Furthermore, it may cause further complications in these patients.
• Hypersensitivity to Cholestyramine: Any patient with a known severe allergy to the resin or any of the inactive ingredients (like specific dyes or flavorings) must not use the medication.

• Severe Constipation: In patients with pre-existing severe constipation, Cholestyramine may lead to fecal impaction or bowel obstruction. The risk-benefit ratio must be carefully weighed.
• Phenylketonuria (PKU): This is a relative contraindication for the aspartame-containing versions of the drug. These patients should use the sucrose-containing versions instead.
• Hemorrhoids: The constipating effect of the resin can severely aggravate existing hemorrhoids, leading to pain and bleeding.
• Triglyceride Levels >300 mg/dL: Cholestyramine can raise triglyceride levels. In patients who already have very high triglycerides, the drug may push levels into a range that increases the risk of acute pancreatitis.

There is no known cross-sensitivity between Cholestyramine and other classes of drugs. However, patients who are sensitive to other bile acid sequestrants (like Colestipol or Colesevelam) may also experience similar gastrointestinal side effects with Cholestyramine, although this is due to the mechanism of action rather than an allergic cross-reactivity.

> Important: Your healthcare provider will evaluate your complete medical history, including the patency of your bile ducts and your baseline triglyceride levels, before prescribing Cholestyramine.

FDA Pregnancy Category C.

Cholestyramine is not absorbed systemically, which theoretically makes it safer than drugs that enter the fetal circulation. However, its interference with the absorption of fat-soluble vitamins (A, D, E, and K) poses a significant risk. Vitamin K deficiency in the mother can lead to neonatal coagulation defects (bleeding problems in the newborn). If Cholestyramine is used during pregnancy, vitamin supplementation is usually required, and the patient must be monitored closely by an obstetrician.

Cholestyramine is not excreted in human milk because it is not absorbed into the mother's bloodstream. However, the potential for the drug to cause vitamin deficiencies in the mother could indirectly affect the nutritional quality of the breast milk. Breastfeeding mothers should discuss vitamin supplementation with their healthcare provider.

Cholestyramine is used in children to treat high cholesterol and certain types of itching. However, the long-term effects of the drug on growth and development are a concern due to potential malabsorption of nutrients.

• Monitoring: Children on this medication must have their growth charts monitored closely.
• Supplements: Most pediatricians will prescribe a daily multivitamin to be taken at the appropriate time interval to prevent deficiencies.
• Age: It is generally not recommended for infants or very young children unless under the direct supervision of a specialist.

Patients over the age of 65 are at a significantly higher risk for the gastrointestinal side effects of Cholestyramine.

• Constipation: The risk of fecal impaction is highest in this group.
• Polypharmacy: Elderly patients often take multiple medications for heart disease or diabetes. The risk of Cholestyramine 'binding' these other drugs is a major concern. Healthcare providers must carefully coordinate the timing of all medications.

No dose adjustment is needed for the drug itself, but these patients are at higher risk for hyperchloremic acidosis. The resin releases chloride, which the kidneys must then manage. If kidney function is poor, the acid-base balance of the body can be disrupted.

Cholestyramine is often used to treat symptoms of hepatic (liver) impairment, such as pruritus. No dose adjustment is required for the liver, but the drug is ineffective if there is a complete blockage of the bile ducts (biliary cirrhosis).

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or are treating a child or elderly family member.

Cholestyramine is a large, insoluble, quaternary ammonium anion-exchange resin. Its molecular structure consists of a styrene-divinylbenzene copolymer with active quaternary ammonium groups.

At the molecular level, these ammonium groups carry a positive charge. Bile acids (such as glycocholic and taurocholic acids) carry a negative charge at the physiological pH of the intestine. Through ionic bonding, the Cholestyramine resin 'swaps' its chloride ions for the bile acid anions. This creates an exceptionally stable, insoluble complex. Because the resin is too large to pass through the intestinal wall, the bound bile acids are trapped and carried through the digestive tract to be excreted in the feces.

• Dose-Response: The reduction in LDL cholesterol is dose-dependent, typically ranging from 15% to 30% reduction at standard doses.
• Onset of Action: For cholesterol reduction, the effect begins within 24-48 hours, but it may take 1 to 4 weeks of consistent use to see the maximum reduction in blood tests. For pruritus, relief may begin within 1 to 3 weeks.
• Duration of Effect: Once the drug is stopped, bile acid reabsorption returns to normal within a few days, and cholesterol levels typically return to baseline within 2 to 4 weeks.

| Parameter | Value |

|---|---|

| Bioavailability | 0% (Not absorbed) |

| Protein Binding | 0% (Does not enter blood) |

| Half-life | N/A (Transit time only) |

| Tmax | N/A (Stays in gut) |

| Metabolism | None |

| Excretion | 100% Fecal |

• Molecular Formula: (C21H26ClN)n (as a repeating polymer unit)
• Molecular Weight: Very high (polymer)
• Solubility: Insoluble in water and organic solvents.
• Description: A white to buff-colored, fine powder with a slight amine-like odor.

Cholestyramine belongs to the Bile Acid Sequestrants class. Other drugs in this class include Colestipol (Colestid) and Colesevelam (Welchol). While they all work by binding bile acids, Colesevelam is often preferred in modern practice because it is available in tablet form and has a lower incidence of gastrointestinal side effects.